Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Francesca Sperandi"'
Autor:
Elisa Andrini, Mirta Mosca, Linda Galvani, Francesca Sperandi, Biagio Ricciuti, Giulio Metro, Giuseppe Lamberti
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Targeted therapy has dramatically changed the history and outcomes of oncogene-addicted non-small-cell lung cancer (NSCLC). RET rearrangements are typically observed in about 1–2% of NSCLC, resulting in constitutive activation of downstream signall
Externí odkaz:
https://doaj.org/article/810b165b7adb43dc9e5707cb1f20d5dc
BRAF‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis
Autor:
Francesca Abbati, Annalisa Altimari, Barbara Corti, Emi Dika, Francesca Sperandi, Barbara Melotti
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2200-2204 (2021)
Abstract We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a
Externí odkaz:
https://doaj.org/article/7dcff667c70b43a28436b01a14ecc4ea
Autor:
Andrea De Giglio, Elisa Tassinari, Arianna Zappi, Alessandro Di Federico, Barbara Lenzi, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Marco Maltoni, Andrea Ardizzoni
Publikováno v:
Cancers, Vol 14, Iss 23, p 5845 (2022)
Background: An acceptable risk-benefit ratio may encourage the prescription of immune checkpoint inhibitors (ICI) near the late stage of life. The lung immune prognostic index (LIPI) was validated in advanced non-small cell lung cancer (NSCLC) patien
Externí odkaz:
https://doaj.org/article/523c5bc9ffa240c7917428e251cffc35
Autor:
Andrea De Giglio, Marta Aprile, Alessandro Di Federico, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Andrea Ardizzoni
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 18, p 10292 (2022)
The impact of baseline versus intercurrent steroids on the efficacy of upfront chemotherapy plus pembrolizumab (CT-ICI) for advanced non-small cell lung cancer (NSCLC) patients is unclear. We conducted a retrospective study on metastatic NSCLC patien
Externí odkaz:
https://doaj.org/article/337f9583f42f46ac94d877bfe743b5e5
Autor:
Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino, Dario De Biase, Francesca Giunchi, Arianna Palladini, Francesca Sperandi, Barbara Melotti, Andrea Ardizzoni
Publikováno v:
Cancers, Vol 14, Iss 14, p 3472 (2022)
Background: In non-small cell lung cancer (NSCLC), BRAF class 1 alterations are effectively targeted by BRAF inhibitors. Conversely, targeted therapies have very low or absent activity in patients carrying class 2 and 3 alterations. The spectrum of B
Externí odkaz:
https://doaj.org/article/fe0c44a139e8458c98646a9f533f94ca
Autor:
Fabiana Perrone, Giulia Mazzaschi, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Rita Nizzoli, Monica Pluchino, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Federica Bertolini, Fausto Barbieri, Stefania Bettelli, Lucia Longo, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Cancers, Vol 14, Iss 8, p 2019 (2022)
Introduction: BRAF mutation involved 2–4% of lung adenocarcinoma. Differences in clinicopathologic features and patient outcome exist between V600E and non-V600E BRAF mutated NSCLC. Thus, we sought to assess the frequency and clinical relevance of
Externí odkaz:
https://doaj.org/article/24526de529bb4f77aa24fda215647c5e
Autor:
Giuseppe Lamberti, Francesco Gelsomino, Stefano Brocchi, Antonio Poerio, Barbara Melotti, Francesca Sperandi, Mauro Gargiulo, Claudio Borghi, Michelangelo Fiorentino, Andrea Ardizzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Atherosclerosis is considered an irreversible process, with crucial contribution of inflammation and immune cells. Impact of cancer immunotherapy on a partly immune-driven disease, such as atherosclerosis, is poorly understood, but preclinical models
Externí odkaz:
https://doaj.org/article/03939e2192414974837dc64dc799c40e
Autor:
Francesca Comito, Rachele Pagani, Giada Grilli, Francesca Sperandi, Andrea Ardizzoni, Barbara Melotti
Publikováno v:
Cancers, Vol 14, Iss 2, p 271 (2022)
The prognosis of patients with advanced cutaneous melanoma has radically changed in the past decade. Nevertheless, primary or acquired resistance to systemic treatment occurs in many cases, highlighting the need for novel treatment strategies. This r
Externí odkaz:
https://doaj.org/article/6876484b754d48e7a32d3e1ba7461a74
Autor:
Rossana Berardi, Candida Mastroianni, Giuseppe Lo Russo, Roberta Buosi, Daniele Santini, Agnese Montanino, Carlo Carnaghi, Marcello Tiseo, Rita Chiari, Andrea Camerini, Sandro Barni, Valeria De Marino, Daris Ferrari, Antonella Cristofano, Laura Doni, Federica Freddari, Daniele Fumagalli, Luigi Portalone, Roberta Sarmiento, Giovanni Schinzari, Francesca Sperandi, Marcello Tucci, Alessandro Inno, Libero Ciuffreda, Marita Mariotti, Cinzia Mariani, Miriam Caramanti, Mariangela Torniai, Rosaria Gallucci, Chiara Bennati, Paola Bordi, Lucio Buffoni, Achille Galeassi, Michele Ghidini, Emidio Grossi, Alessandro Morabito, Bruno Vincenzi, Emanuela Arvat
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Hyponatremia in cancer patients is often caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The aim of this observational multicenter study was to analyze the medical and economic implications of SIADH in this
Externí odkaz:
https://doaj.org/article/35962965fe4b448a9213dbbff50072dc
Autor:
Emi Dika, Martina Lambertini, Cristina Pellegrini, Giulia Veronesi, Barbara Melotti, Mattia Riefolo, Francesca Sperandi, Annalisa Patrizi, Costantino Ricci, Martina Mussi, Maria Concetta Fargnoli
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3, p 478 (2021)
Melanomas arising at uncommon sites include a group of lesions related to unusual localizations in specific ethnic groups. The rarity of the disease often represents a limit to the participation of patients in specific trials. However, this peculiar
Externí odkaz:
https://doaj.org/article/00b1494f770b4b89ada34ac096baf769